Clinical Trial Update: Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations [Phase 3]

View source ↗

Summary

Phase 3 trial of crenolanib in combination with chemotherapy for relapsed or refractory acute myeloid leukemia with activating FLT3 mutations has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Crenolanib (Crenolanib)

Snippet

Sponsor: University of Ulm | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: TERMINATED